Laurie Keating insider trades
Open-market stock purchases and sales by Laurie Keating, Unknown at Kalaris Therapeutics, Inc, from SEC Form 4 filings since May 1, 2015.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging +18%.
Companies traded
- KLRS Kalaris Therapeutics, Inc: other filings, last Aug 1, 2026
- PEPG PepGen Inc: 1 buy, last Jun 18, 2026
- IMRX Immuneering Corp: 2 buys, last Jun 11, 2026
- IMGO Imago BioSciences, Inc: other filings, last Jan 11, 2023
- ALNY Alnylam Pharmaceuticals, Inc: 1 buy, 38 sales, last Aug 5, 2021
- ALKS Alnylam Pharmaceuticals, Inc: 3 sales, last Dec 29, 2017